Health
Merck ends COVID vaccine program, cites inferior immune responses – Reuters
Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental…
(Reuters) – Drugmaker Merck & Co said on Monday it would stop development of its two COVID-19 vaccines and focus pandemic research on treatments, with initial data on an experimental oral antiviral expected by the end of March.
FILE PHOTO: A scientist is seen in the Themis Bioscience laboratory in Vienna, Austria, in this undated handout photo. Themis Bioscience/Martin Wacht/Handout via REUTERS /File Photo
Merck was late to join the race to develop a vaccine to protect against the coronavirus, which…
-
Noosa News22 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News23 hours agoMotorcyclist dies in crash with truck
-
Noosa News24 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Noosa News22 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
